Journal of Clinical Oncology, Vol 23, No 14 (May 10), 2005: pp. 3212-3218
© 2005 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.11.486
Lung Cancer in Women
Jyoti D. Patel
From the Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
Address reprint requests to Jyoti D. Patel, MD, Division of Hematology/Oncology, Northwestern University, 676 N St Clair Street, Suite 850, Chicago, IL 60611; e-mail: jd-patel{at}northwestern.edu.
Lung cancer is the leading cause of cancer death in the United States and is responsible for 20,000 more deaths yearly in US women than breast cancer. Cigarette smoking is the major cause of lung cancer, and unfortunately, approximately 22 million US women smoke. Mounting evidence suggests that there are significant differences in lung cancer between the sexes. There is a difference in the histologic distribution of lung cancer, with glandular differentiation being more common in women. Genetic variation may account for differences in susceptibility, and hormonal and biologic factors may play a role in carcinogenesis. Lung cancer patients have few therapeutic options. A more thorough understanding of the heterogeneity of lung cancer across populations may lead to innovations in treatment and prevention strategies.
Author's disclosures of potential conflicts of interest are found at the end of this article.
This article has been cited by other articles:

|
 |

|
 |
 
M. Tsuchiya, M. Iwasaki, T. Otani, J.-i. Nitadori, K. Goto, Y. Nishiwaki, Y. Uchitomi, and S. Tsugane
Breast Cancer in First-degree Relatives and Risk of Lung Cancer: Assessment of the Existence of Gene-Sex Interactions
Jpn. J. Clin. Oncol.,
June 23, 2007;
(2007)
hym048v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. V. Karamouzis, P. A. Konstantinopoulos, and A. G. Papavassiliou
The Activator Protein-1 Transcription Factor in Respiratory Epithelium Carcinogenesis
Mol. Cancer Res.,
February 1, 2007;
5(2):
109 - 120.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Shen, J. Liu, Y. Xie, B. A. Diwan, and M. P. Waalkes
Fetal Onset of Aberrant Gene Expression Relevant to Pulmonary Carcinogenesis in Lung Adenocarcinoma Development Induced by In Utero Arsenic Exposure
Toxicol. Sci.,
February 1, 2007;
95(2):
313 - 320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Gray
The consequences of the unregulated cigarette.
Tob. Control,
October 1, 2006;
15(5):
405 - 408.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M Dougherty, W. Mazhawidza, A. R Bohn, K. A Robinson, K. A Mattingly, K. A Blankenship, M. O Huff, W. G McGregor, and C. M Klinge
Gender difference in the activity but not expression of estrogen receptors {alpha} and {beta} in human lung adenocarcinoma cells.
Endocr. Relat. Cancer,
March 1, 2006;
13(1):
113 - 134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Schabath, X. Wu, Q. Wei, G. Li, J. Gu, and M. R. Spitz
Combined Effects of the p53 and p73 Polymorphisms on Lung Cancer Risk
Cancer Epidemiol. Biomarkers Prev.,
January 1, 2006;
15(1):
158 - 161.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|